Literature DB >> 31310181

Solid Pseudopapillary Neoplasms of the Pancreas: Clinicopathologic and Radiologic Features According to Size.

Riccardo De Robertis1, Giovanni Marchegiani2, Matteo Catania3, Maria Chiara Ambrosetti3, Paola Capelli4, Roberto Salvia2, Mirko D'Onofrio3.   

Abstract

OBJECTIVE. The purpose of this study was to retrospectively analyze and correlate clinicopathologic and radiologic features of resected solid pseudopapillary neoplasms of the pancreas according to their size. MATERIALS AND METHODS. Clinicopathologic and radiologic features of 106 resected solid pseudopapillary neoplasms of the pancreas over a 20-year period were retrospectively analyzed. Tumors were divided into three groups according to their size (≤ 30 mm, 31-50 mm, and ≥ 51 mm). Clinicopathologic and radiologic features were compared among groups using Kruskal-Wallis and Fisher exact tests. RESULTS. Forty-one tumors that were 30 mm or smaller, 30 tumors between 31 and 50 mm, and 35 tumors that were 51 mm or larger were included. Preoperative MRI of 76 patients and CT of 40 patients were examined. Patients with tumors that were 30 mm or smaller were significantly older than the other groups of patients (p = 0.038). Large tumors (31-50 and ≥ 51 mm) were more frequently located in the pancreatic body or tail (p = 0.008). Most tumors had well-defined margins (87.7%) and a mixed solid and cystic appearance (54.7%) at imaging; tumors that were 30 mm or smaller were more frequently entirely solid (p = 0.028). At histologic analysis, 13 tumors had at least one feature of malignancy; nodal and liver metastases were found in one patient (0.9%). No significant differences between groups were found regarding the presence of malignant histologic features (p = 0.932). The rate of incorrect preoperative diagnosis was higher in tumors 30 mm or smaller, albeit without significant differences between groups (p = 0.561). CONCLUSION. Malignancy in solid pseudopapillary neoplasms is not correlated with tumor size; tumors that are 30 mm or smaller may present atypical imaging features, which may overlap those of other solid tumors of the pancreas.

Entities:  

Keywords:  CT; MRI; pancreas; pathology; solid pseudopapillary neoplasm

Year:  2019        PMID: 31310181     DOI: 10.2214/AJR.18.20715

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  5 in total

1.  Clinicopathological and immunohistochemical study of 29 cases of solid-pseudopapillary neoplasms of the pancreas in patients under 20 years of age along with detailed review of literature.

Authors:  Nasir Ud Din; Shabina Rahim; Jamshid Abdul-Ghafar; Arsalan Ahmed; Zubair Ahmad
Journal:  Diagn Pathol       Date:  2020-12-09       Impact factor: 2.644

2.  Solid-Pseudopapillary Neoplasm of the Pancreas: A 63-Case Analysis of Clinicopathologic and Immunohistochemical Features and Risk Factors of Malignancy.

Authors:  Hongchun Chen; Yuchen Huang; Ningning Yang; Wentian Yan; Ruxue Yang; Shan Zhang; Panpan Yang; Nan Li; Zhenzhong Feng
Journal:  Cancer Manag Res       Date:  2021-04-15       Impact factor: 3.989

3.  Clinical Pattern of Preoperative Positron Emission Tomography/Computed Tomography (PET/CT) Can Predict the Aggressive Behavior of Resected Solid Pseudopapillary Neoplasm of the Pancreas.

Authors:  Ji-Su Kim; Emmanuel Ii-Uy Hao; Seoung-Yoon Rho; Ho-Kyoung Hwang; Woo-Jung Lee; Dong-Sub Yoon; Chang-Moo Kang
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

4.  Solid pseudopapillary neoplasm of the pancreas in a young male with main pancreatic duct dilatation: A case report.

Authors:  Saki Nakashima; Yoshiki Sato; Tsunao Imamura; Daisuke Hattori; Tetsuo Tamura; Rikako Koyama; Junichiro Sato; Yuta Kobayashi; Masaji Hashimoto
Journal:  World J Clin Cases       Date:  2021-12-26       Impact factor: 1.337

5.  Diagnosis and treatment of solid pseudopapillary neoplasm of the pancreas in children: A report of 18 cases.

Authors:  Ayiguzaili Maimaijiang; Haiyun Wang; Wanfu Li; Yaqi Wang
Journal:  Front Pediatr       Date:  2022-08-08       Impact factor: 3.569

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.